Developing an intervention for HIV, hepatitis C, and opioid use among people who inject drugs along the Texas-Mexico border
Proyecto Vida: Developing an HIV, HCV and opioid use MOST intervention for persons who inject drugs along the Texas-Mexico Border
This study is working to find the best ways to help Latino people in Ciudad Juárez who use drugs and are dealing with HIV and hepatitis C by testing different support options like peer guidance, HIV testing, and safe syringe services to improve their health and well-being.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11085858 on NIH RePORTER |
What this research studies
This research focuses on creating a comprehensive intervention to address the intertwined issues of HIV, hepatitis C (HCV), and opioid use among Latino individuals who inject drugs in Ciudad Juárez, Mexico. The project employs a multiphase optimization strategy (MOST) to develop and test various intervention components, including peer navigation for HCV treatment, HIV testing and education, opioid agonist treatment, and syringe services. By optimizing these components, the research aims to improve health outcomes and reduce the prevalence of these conditions in a high-risk population. The study will also involve assessing the feasibility and acceptability of these interventions through a factorial experiment.
Who could benefit from this research
Good fit: Ideal candidates for this research are Latino individuals who inject drugs and live along the Texas-Mexico border, particularly in underserved areas like Ciudad Juárez.
Not a fit: Patients who do not inject drugs or those living outside the targeted geographic area may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the rates of HIV and HCV among people who inject drugs, improving overall health and quality of life for this vulnerable population.
How similar studies have performed: Previous research has shown success in using similar intervention strategies to address HIV and HCV among high-risk populations, indicating potential for positive outcomes in this study.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Ludwig-Barron, Natasha — University of California, San Francisco
- Study coordinator: Ludwig-Barron, Natasha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.